Curewin Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 10-12-2024
- Paid Up Capital ₹ 5.00 M
as on 10-12-2024
- Company Age 34 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.10 Cr
as on 10-12-2024
- Satisfied Charges ₹ 1.19 Cr
as on 10-12-2024
- Revenue 9878.55%
(FY 2023)
- Profit 7383.07%
(FY 2023)
- Ebitda 8755.61%
(FY 2023)
- Net Worth 9999.81%
(FY 2023)
- Total Assets 7626.89%
(FY 2023)
About Curewin Pharmaceuticals
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 5.00 M.
The company currently has active open charges totaling ₹1.10 Cr. The company has closed loans amounting to ₹1.19 Cr, as per Ministry of Corporate Affairs (MCA) records.
Virendra Tare, Sindhu Tare, Rajendra Tare, and One other member serve as directors at the Company.
- CIN/LLPIN
U24232MP1990PTC006038
- Company No.
006038
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
09 Oct 1990
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Gwalior
Industry
Company Details
- Location
Indore, Madhya Pradesh, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Curewin Pharmaceuticals Private Limited offer?
Curewin Pharmaceuticals Private Limited offers a wide range of products and services, including Cardiovascular Drugs & Medication, Cardiac Drugs, Anti Infective Drugs & Medicines, Malaria Medicine, Cosmetics, Hair & Beauty Products, Body Cream, Surgical & ICU Equipments, Respiratory Therapy Equipment, Tea & Coffee, Herbal Tea.
Who are the key members and board of directors at Curewin Pharmaceuticals?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Virendra Tare  | Director | 06-May-2016 | Current |
| Sindhu Tare | Director | 01-Apr-2005 | Current |
| Rajendra Tare | Director | 21-Apr-2008 | Current |
| Sanjay Tiwari | Director | 06-Nov-2019 | Current |
Financial Performance of Curewin Pharmaceuticals.
Curewin Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 9878.55% increase. The company also saw a substantial improvement in profitability, with a 7383.07% increase in profit. The company's net worth Soared by an impressive increase of 9999.81%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Curewin Pharmaceuticals?
Unlock access to Curewin Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 09 Mar 2021 | ₹1.00 M | Open |
Hdfc Bank Limited Creation Date: 08 Oct 2011 | ₹1.00 Cr | Open |
State Bank Of Indore Creation Date: 19 Nov 2009 | ₹0.35 M | Satisfied |
How Many Employees Work at Curewin Pharmaceuticals?
Unlock and access historical data on people associated with Curewin Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Curewin Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Curewin Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
